Skip to search formSkip to main contentSkip to account menu

Siramesine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Siramesine and lapatinib induce synergic cell death via a ferroptotic mechanism in lung adenocarcinoma and glioblastoma cells
2009
2009
Syddansk Universitet High-affinity small molecule-phospholipid complex formation: binding of siramesine to phosphatidicacid
Siramesine (SRM) is a σ-2 receptor agonist which has been recently shown to inhibit growth of cancer cells. Fluorescence… 
2004
2004
How to use the siramesine in the treatment of cancer
The present invention relates to the treatment of cancer. In particular, the present invention provides a cancer therapeutic…